Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1976 Jun;52(608):373-8.
doi: 10.1136/pgmj.52.608.373.

Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine

Clinical Trial

Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine

W G Laver et al. Postgrad Med J. 1976 Jun.

Abstract

A vaccine was prepared containing the haemagglutinin and neuraminidase subunits from the A/Port Chalmers. 1/73 (H3N2) strain of influenza virus. The virus particles were disrupted with ammonium deoxycholate and the matrix protein, which was insoluble in this detergent, was removed by centrifugation. Following removal of deoxycholate, the haemagglutinin and neuraminidase subunits aggregated by their hydrophobic ends, forming mixed clusters. These were then freed from nucleocapsids by electrophoresis.

The haemagglutinin and neuraminidase subunits were as effective as intact inactivated virus (at equivalent concentration) in eliciting a late primary antibody response when injected in saline into rabbits.

In humans also, the subunits were as immunogenic as intact inactivated virus particles at equivalent concentration. Many people, however, responded only to the ‘common’ antigenic determinant(s) on the haemagglutinin subunit of Port Chalmers/73 virus and did not respond at all to the ‘specific’ determinant(s). Sera from these people contained antibodies which reacted equally as well with Hong Kong/68 virus as with the Port Chalmers/73 strain and none which reacted exclusively with the latter virus.

PubMed Disclaimer

References

    1. Am J Dis Child. 1949 Sep;78(3):295-301 - PubMed
    1. J Mol Biol. 1964 Jul;9:109-24 - PubMed
    1. J Exp Med. 1974 Dec 1;140(6):1571-8 - PubMed
    1. Virology. 1974 May;59(1):230-44 - PubMed
    1. Adv Immunol. 1973;17:195-253 - PubMed

Publication types